Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-062654)

Filing Details

Accession Number:: 0001209191-22-062654
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-23 17:11:38
Reporting Period:: 2022-12-01

Accepted Time:: 2022-12-23 17:11:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1490829	James Jones	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-12-01	31	$2.33	25,657	No	4	P	Direct
Common Stock	Acquisiton	2022-12-02	31	$2.31	25,688	No	4	P	Direct
Common Stock	Acquisiton	2022-12-05	31	$2.19	25,719	No	4	P	Direct
Common Stock	Acquisiton	2022-12-06	31	$2.19	25,750	No	4	P	Direct
Common Stock	Acquisiton	2022-12-07	31	$2.18	25,781	No	4	P	Direct
Common Stock	Acquisiton	2022-12-08	31	$2.19	25,812	No	4	P	Direct
Common Stock	Acquisiton	2022-12-09	31	$2.15	25,843	No	4	P	Direct
Common Stock	Acquisiton	2022-12-12	31	$2.14	25,874	No	4	P	Direct
Common Stock	Acquisiton	2022-12-13	40	$2.18	25,914	No	4	P	Direct
Common Stock	Acquisiton	2022-12-14	40	$2.21	25,954	No	4	P	Direct
Common Stock	Acquisiton	2022-12-15	20	$2.24	25,974	No	4	P	Direct
Common Stock	Acquisiton	2022-12-16	40	$2.22	26,014	No	4	P	Direct
Common Stock	Acquisiton	2022-12-19	70	$2.21	26,084	No	4	P	Direct
Common Stock	Acquisiton	2022-12-20	121	$2.31	26,205	No	4	P	Direct
Common Stock	Acquisiton	2022-12-21	88	$2.22	26,293	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.